3
Orphan Designations
0
FDA Approvals
4
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| gastric cancer | antibody-drug conjugate consisting of an anti-human epidermal growth factor receptor 2 bispecific antibody conjugated to a topoisomerase I inhibitorFC-fusion bispecific antibody targeting extracellular domains II and IV of HER 2 and FC-fusion bispecific IgG1 antibody inhibiting PD-L1 and CTLA-4 | Orphan Designation | - |
| thymic epithelial neoplasm | humanized bispecific IgG1 antibody that can simultaneously bind to both programmed death-ligand 1 and cytotoxic T-lymphocyte-associated protein 4 | Orphan Designation | - |
| thymoma | humanized bispecific IgG1 antibody that can simultaneously bind to both programmed death-ligand 1 and cytotoxic T-lymphocyte-associated protein 4 | Orphan Designation | - |
| thymoma type AB | humanized bispecific IgG1 antibody that can simultaneously bind to both programmed death-ligand 1 and cytotoxic T-lymphocyte-associated protein 4 | Orphan Designation | - |